Tariro Makadzange is a medical social entrepreneur, infectious disease physician, and expert in viral immunology. She earned her MD from Harvard Medical School and a DPhil (PhD) from Oxford University (Balliol College). Her career spans public healthcare in Zimbabwe, global health research between Massachusetts General Hospital and the University of Zimbabwe, and clinical development in the pharmaceutical industry-from first-in-human biologics to late-phase small molecule trials. She has conducted research in viral immunology and vaccine immunogen design. As the founder of CRMG and Mutala Trust, she has led efforts to diversify clinical trials, advance immunogenetics research in African populations, and drive public health innovation. Now, as the CEO of ACRN, Dr. Makadzange is building a pan-African clinical research ecosystem with her team that aims to deliver globally competitive, high-quality trials while tackling Africa’s most pressing health challenges. She also serves as an Assistant Clinical Professor at Stanford University and a Faculty Fellow at the Stanford Center for Innovation in Global Health.
